Morphine, the microbiome, and fatty acids: short chains make a big link in opioid reward.
Morphine, the microbiome, and fatty acids: short chains make a big link in opioid reward.
复制标题
吗啡、微生物组和脂肪酸:短链在阿片类药物奖励中发挥着重要作用。
DOI:
10.1038/s41386-021-01093-4
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Day,JeremyJ
中科院分区:
文献类型:
--
作者:
Tuscher,JenniferJ;Day,JeremyJ
Influences of the gastrointestinal tract on mood and mental health have been recognized for centuries, and accumulating results over the past decade have supported a key role for gut bacteria (collectively known as the gut microbiome) in many aspects of brain health and disease [1]. While the mechanistic underpinnings of microbiome-brain interactions are complex, emerging evidence suggests that gut microbiota produce multiple brain-penetrant metabolites with gene regulatory potential, such as co-factors for epigenetic modifications [2–4]. This observation has the potential to link differences in gut microbiota to dysregulated gene expression and chromatin patterns that are observed in multiple neuropsychiatric disorders, including major depression, stressrelated conditions, and substance abuse [5]. Although bacterial metabolites have recently been implicated in the orchestration of gut-brain interactions [2], evidence supporting a direct role for specific factors in complex motivated behaviors and drug-induced transcriptional reprogramming remains limited. In this issue of Neuropsychopharmacology, Hofford et al.[6] explored the contribution of gut microbiome diversity and composition in morphine conditioned place preference (CPP) and locomotor sensitization using an oral antibiotic knockdown model (Abx; an antibiotic cocktail delivered via drinking water). The authors first show that oral antibiotic administration reduced bacterial complexity and altered the relative proportion of bacterial phyla, including decreases in Firmicutes bacteria. This common gut microbiome phylum is found in healthy individuals and is known to generate short-chain fatty acids (SCFAs)(such as butyrate), which act both as histone deacetylase inhibitors and are further metabolized into co-factors for acetylation of histone proteins. Notably, loss of bacterial diversity was associated with decreased levels of at least two SCFAs produced by gut bacteria—butyrate and propionate. Next, the manuscript reports that microbiome depletion blunts morphine locomotor sensitization and abolishes morphine CPP, commonly used measures of behavioral effects of drugs. Even more strikingly, morphine CPP was completely restored when drinking water was supplemented with SCFAs, demonstrating reversible control of morphine reward as well as necessity for SCFAs in this process. Given that SCFAs have a known role in gene regulation via epigenetic modulation, Hofford and colleagues next explored whether oral Abx also alters transcriptional changes in the nucleus accumbens (a key brain region linked to drug reward) following repeated morphine administration. Consistent with behavioral observations, microbiome depletion resulted in a dramatically distinct transcriptional responses to morphine, as measured with RNA-seq. While a number of genes were similarly altered by morphine in both control and Abx conditions, microbiome depletion also resulted in additional morphine-regulated changes, largely in functional categories related to histone modification and chromatin dynamics. In addition, SCFA replenishment restored transcriptional changes induced by Abx at several genes, including inducible transcription factors previously identified to be important in drug responses (eg, the immediate early genes Egr2 and Egr4). Thus, like the behavioral effects of microbiome depletion, at least some effects on morphine-induced gene expression changes are reversible when SCFAs are replaced in the diet.Together, these findings mark a fundamental first step for continued exploration of gut-brain interactions in the regulation of morphine action. However, many additional questions remain. For …